WebNews

Please enter a web search for web results.

NewsWeb

TMX Newsfile
newsfilecorp. com > release > 299143 > Balance-Medical-Announces-Dermatology-Care-Now-Available-in-Bismarck-as-Patient-Access-Becomes-a-Growing-Concern

Balance Medical Announces Dermatology Care Now Available in Bismarck as Patient Access Becomes a Growing Concern

1+ hour, 46+ min ago  (19+ words) Bismarck, North Dakota--(Newsfile Corp. - May 27, 2026) - Balance Medical has announced that dermatology care is now available at. .....

Symbols: btc-usd,nasdaq:sbc
Yahoo Finance
finance. yahoo. com > sectors > healthcare > articles > vanda-pharmaceuticals-announces-orphan-drug-110000929. html

Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis

8+ hour ago  (340+ words) WASHINGTON, May 27, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation to imsidolimab, a high'affinity humanized immunoglobulin G4 (Ig G4) monoclonal antibody, for the treatment of generalized pustular…...

Symbols: nasdaq:vnda,nasdaq:anab
markets. businessinsider. com
markets. businessinsider. com > news > stocks > medicenna-and-fondazione-melanoma-onlus-announce-first-patient-dosed-in-the-neo-cyt-study-of-mdna11-in-neoadjuvant-melanoma-1036142510

Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma

2+ week, 1+ day ago  (159+ words) NEO-CYT marks the first evaluation of MDNA11 in earlier-stage cancers, as a potentially curative treatment; extends development beyond the heavily pretreated metastatic setting of the ongoing Phase 1/2 ABILITY-1 study" NEO-CYT is a Phase 1b randomized, multi-centre trial sponsored by Fondazione Melanoma Onlus…...

Symbols: nasdaq:cstl,tsx:mdna
The Globe and Mail
theglobeandmail. com > investing > markets > stocks > MDNA-T > pressreleases > 1615714 > medicenna-and-fondazione-melanoma-onlus-announce-presentation-on-neocyt-trial-at-asco-2026

Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026

3+ week, 6+ day ago  (771+ words) TORONTO and HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (Medicenna" or the Company") (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing. .. Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026 TORONTO and HOUSTON, April 30, 2026 (GLOBE NEWSWIRE)…...

Symbols: tsx:mdna
markets. businessinsider. com
markets. businessinsider. com > news > stocks > canadian-dermatology-association-in-partnership-with-melanoma-canada-offer-free-skin-cancer-screenings-on-parliament-hill-1036197621

Canadian Dermatology Association in Partnership with Melanoma Canada Offer Free Skin Cancer Screenings on Parliament Hill

6+ hour ago  (609+ words) As skin cancer rates continue to rise across the country, the Canadian Dermatology Association (CDA) is proud to provide a public screening event in partnership with Melanoma Canada. The Melanoma. .. Canadian Dermatology Association in Partnership with Melanoma Canada Offer Free…...

Symbols: nasdaq:cstl
healiotwo
healio. com > news > dermatology > 20/26/0527 > dozens-of-treatments-for-chronic-itch-under-investigation

Dozens" of treatments for chronic itch under investigation

5+ hour, 53+ min ago  (57+ words) CLEVELAND — After more than a decade with no new medications for chronic spontaneous urticaria, clinicians are beginning to see rapid progress, according to a speaker at the Medical Dermatology Therapy Update IV. FDA approvals of the biologic dupilumab (Dupixent, Sanofi…...

Symbols: btc-usd,euronext:san,nasdaq:sny
EWN
ewn. co. za > tattoo-cancer-fears-grow-after-new-study-links-ink-to-lymphoma-risk

Tattoo cancer fears grow after new study links ink to lymphoma risk

13+ hour, 54+ min ago  (522+ words) 27 May 2026 13: 00 27 May 2026 12: 56 Gavin Hunt signs new two-year deal with Stellenbosch FC 27 May 2026 12: 05 LIVE | Announcement of Bafana Bafana squad with Robert Marawa Tattoos are more popular than ever, but new research linking tattoo ink to cancer risk is sparking fresh concern…...

Symbols: icp-ms
Tenerife Weekly News
tenerifeweekly. com > 05/27/2026 > first-atopic-dermatitis-school-in-tenerife-huc-launches-pioneering-initiative-to-enhance-patient-wellbeing

First Atopic Dermatitis School in Tenerife: HUC Launches Pioneering Initiative to Enhance Patient Wellbeing

12+ hour, 48+ min ago  (211+ words) The training programme, coordinated directly by the Dermatology Department of the HUC, began with a specialist presentation titled "Atopic Dermatitis: Pathology, Epidemiology, and Self-Care. Dermatologists Mar'a Arteaga Henr'quez, Mar'a del Mar Pestana Eliche, and third-year resident Daniel S'nchez B'ez explained…...

Symbols: hecsi-75,btc-usd,eth-usd
Cleveland Clinic
health. clevelandclinic. org > environmental-triggers-of-systemic-mastocytosis

Environmental Triggers of Systemic Mastocytosis

14+ hour, 58+ min ago  (1129+ words) Everyday exposures, like fragrances, cleaning supplies and pollen, can trigger symptoms When you're living with systemic mastocytosis (SM), everyday life can feel like detective work. Symptoms vary widely from person to person, so figuring out what's behind your flares isn't…...

Symbols: btc-usd
The Dermatology Digest
thedermdigest. com > can-melanoma-be-detected-before-it-becomes-visible

Can Melanoma Be Detected Before It Becomes Visible?

22+ hour, 24+ min ago  (335+ words) SMEAR-ULM, a new high-tech system, may detect skin cancers at their earliest stages by measuring tiny temperature variations at the surface of the skin, according to research in mice out of the Universit" de Montr"al, and scientists at Universit…...

Symbols: scib.st,btc-usd